SCHEMBL7657195

SCHEMBL7657195

COC(=O)C(NC(=O)c1ccc(-c2ccc(C)nc2C(=O)Nc2ccc(C(=N)N)cc2)c(C(=O)O)c1)C(C)C

nearest known ligand 0.62

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
F7 P08709 19/20 0.62
F2 P00734 18/20 0.62
F10 P00742 18/20 0.62
PRSS1 P07477 3/20 0.62
PRSS2 P07478 3/20 0.62
PRSS3 P35030 3/20 0.62
F9 P00740 3/20 0.62
PLAU P00749 2/20 0.62
F11 P03951 2/20 0.62
F3 P13726 16/20 0.51
PLG P00747 9/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7657212 1.00 F7 (0.62) F7F2F10PRSS1PRSS2
SCHEMBL7653765 0.93 F7 (0.59) F7F2F10PRSS1PRSS2
SCHEMBL7653760 0.93 F7 (0.59) F7F2F10PRSS1PRSS2
SCHEMBL7690903 0.90 F7 (0.56) F7F2F10PRSS1PRSS2
SCHEMBL7690905 0.90 F7 (0.56) F7F2F10PRSS1PRSS2
SCHEMBL7663284 0.89 F7 (0.52) F7F2F10PRSS1PRSS2
SCHEMBL7663296 0.89 F7 (0.52) F7F2F10PRSS1PRSS2
SCHEMBL7655533 0.88 F7 (0.64) F7F2F10PRSS1PRSS2
SCHEMBL7665788 0.86 F7 (0.64) F7F2F10PRSS1PRSS2
SCHEMBL7665796 0.86 F7 (0.64) F7F2F10PRSS1PRSS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6358960-B1 FOR THERAPY OF INTRAVASCULAR COAGULATION, CORONARY THROMBOSIS, CEREBRAL INFARCTION, CEREBRAL EMBOLISM, TRANSIENT ISCHEMIC ATTACK, CEREBROVASCULAR DISORDERS, PULMONARY VASCULAR DISEASES, DEEP VENOUS THROMBOSIS, ETC. ONO PHARMACEUTICAL CO., LTD. (JP) 2002-03-19 US claimed
EP-1078917-A1 AMIDINO DERIVATIVES AND DRUGS CONTAINING THE SAME AS THE ACTIVE INGREDIENT ONO PHARMACEUTICAL CO., LTD. (JP) 2001-02-28 EP claimed
US-6358960-B1 FOR THERAPY OF INTRAVASCULAR COAGULATION, CORONARY THROMBOSIS, CEREBRAL INFARCTION, CEREBRAL EMBOLISM, TRANSIENT ISCHEMIC ATTACK, CEREBROVASCULAR DISORDERS, PULMONARY VASCULAR DISEASES, DEEP VENOUS THROMBOSIS, ETC. ONO PHARMACEUTICAL CO., LTD. (JP) 2002-03-19 US disclosed
EP-1078917-A1 AMIDINO DERIVATIVES AND DRUGS CONTAINING THE SAME AS THE ACTIVE INGREDIENT ONO PHARMACEUTICAL CO., LTD. (JP) 2001-02-28 EP disclosed